PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $233,328 | +248.3% | 5,823 | +425.5% | 0.01% | +400.0% |
Q2 2021 | $67,000 | -95.9% | 1,108 | -97.7% | 0.00% | -97.1% |
Q1 2020 | $1,615,000 | -64.8% | 48,159 | -52.4% | 0.03% | -49.3% |
Q4 2019 | $4,585,000 | -30.1% | 101,219 | -41.3% | 0.07% | -30.2% |
Q3 2019 | $6,563,000 | -92.3% | 172,380 | -89.3% | 0.10% | -92.9% |
Q1 2016 | $85,347,000 | – | 1,610,932 | – | 1.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |